Investment
Features
FeesSafety
Academy
More
Pluang+

LPL Financial upgraded to buy with strong growth and attractive valuation forecast for 2026+

Analyst Insights
05 Jun 2026
Seeking Alpha
View Source
Bullish
pluang ai news

LPL Financial Holdings Inc. has been upgraded to a buy rating due to its attractive valuation and strong projected earnings growth for 2026 and beyond. In Q1, LPL saw a 30% year-over-year increase in client assets to $2.3 trillion, maintained robust pre-tax margins, and resumed share buybacks. Despite underperforming broader market indexes like SPY and XLF, LPL targets mid- to high single-digit organic growth and a potential stock price upside to $336 per share at a 16x price-to-earnings ratio. Key risks include margin pressure from AI, challenges in mergers and acquisitions amid high valuations, and advisor retention issues.

More News

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
45 minutes ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
49 minutes ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
49 minutes ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
49 minutes ago
Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...

Others
Neutral
49 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App